Late Sunday afternoon, news broke that Qlife Holding and Hipro Biotechnology are extending their letter of intent regarding a potential reverse acquisition. The transaction, which was announced on June 5, is now set to be completed no later than December 31, 2025, and both parties are said to have maintained their commitment to closing the deal.
Read the full article at biostock.se:
https://biostock.se/en/2025/10/qlife-forlanger-avsiktsforklaring-hipro-biotechnology/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
© Modular Finance, source Nordic Press Releases